artificial intelligence

News

EMA and FDA agree 'principles' for AI in drug development

The FDA and EMA have come up with guiding principles that they say will underpin future guidance on the use of AI technologies in drug development.

News

Hippocratic AI builds in life sciences with Grove AI buy

Hippocratic AI has expanded with the acquisition of Grove AI, a specialist in AI used in pharma R&D, building on its patient-facing GenAI agents.

News

JPM: Illumina launches 'unprecedented' disease biology atlas

Illumina says its new Billion Cell Atlas can be used to identify and validate drug targets and train AI models used in drug discovery.

News

JPM: Anthropic reveals its answer to ChatGPT for Health

Anthropic has launched Claude for Healthcare, a suite of AI tools designed for health systems, payers, and patients.

News

Now Iktos teams up with Pierre Fabre in oncology

As Servier announces its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has revealed an integrated collaboration with Iktos

News

Iktos' Chemspeed robotics-powered chemistry platform

Servier signs €1bn-plus AI pact with Iktos

In its second AI-focused drug discovery deal in the space of a week, Servier has announced a €1bn partnership with France's Iktos.

EMA and FDA agree 'principles' for AI in drug development

Hippocratic AI builds in life sciences with Grove AI buy

JPM: Illumina launches 'unprecedented' disease biology atlas

JPM: Anthropic reveals its answer to ChatGPT for Health

Now Iktos teams up with Pierre Fabre in oncology

Servier signs €1bn-plus AI pact with Iktos

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

artificial intelligence

Editor's Picks